This repeatability brings us to predict that many new pathogenic mutations will be discovered in GNA-dependent diseases, falling on the amino acid sites equivalent to the mutations already known in e.g., GNAO1 encephalopathy (Fig. 3). This evidence concerns the gene GNAO1 and Encephalopathy.